These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35764076)

  • 61. Survey of keyword adjustment of published articles medical subject headings in journal of mazandaran university of medical sciences (2009-2010).
    Kabirzadeh A; Siamian H; Abadi EB; Saravi BM
    Acta Inform Med; 2013; 21(2):98-102. PubMed ID: 24058249
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Impact of pharmacists providing a prescription review and monitoring service in ambulatory care or community practice.
    Tully MP; Seston EM
    Ann Pharmacother; 2000 Nov; 34(11):1320-31. PubMed ID: 11098348
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Using Belgian pharmacy dispensing data to assess antibiotic use for children in ambulatory care.
    Dillen H; Burvenich R; De Burghgraeve T; Verbakel JY
    BMC Pediatr; 2022 Jan; 22(1):12. PubMed ID: 34980037
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Improving the quality of publications in and advancing the paradigms of clinical and social pharmacy practice research: The Granada statements.
    Fernandez-Llimos F; Desselle S; Stewart D; Garcia-Cardenas V; Babar ZU; Bond C; Dago A; Jacobsen R; Nørgaard LS; Polidori C; Sanchez-Polo M; Santos-Ramos B; Shcherbakova N; Tonin F
    Res Social Adm Pharm; 2023 May; 19(5):830-835. PubMed ID: 36804321
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Systematic review of pragmatic randomised control trials assessing the effectiveness of professional pharmacy services in community pharmacies.
    Varas-Doval R; Saéz-Benito L; Gastelurrutia MA; Benrimoj SI; Garcia-Cardenas V; Martinez-Martínez F
    BMC Health Serv Res; 2021 Feb; 21(1):156. PubMed ID: 33596906
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Public attitudes towards community pharmacy in Arabic speaking Middle Eastern countries: A systematic review.
    El Hajj MS; Mekkawi R; Elkaffash R; Saleh R; El Awaisi A; Wilbur K
    Res Social Adm Pharm; 2021 Aug; 17(8):1373-1395. PubMed ID: 33257161
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Identifying opportunities to advance practice at a large academic medical center using the ASHP Ambulatory Care Self-Assessment Tool.
    Martirosov AL; Michael A; McCarty M; Bacon O; DiLodovico JR; Jantz A; Kostoff D; MacDonald NC; Mikulandric N; Neme K; Sulejmani N; Summers BB
    Am J Health Syst Pharm; 2018 Jul; 75(13):987-992. PubMed ID: 29844135
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Community pharmacy interventions for health promotion: effects on professional practice and health outcomes.
    Steed L; Sohanpal R; Todd A; Madurasinghe VW; Rivas C; Edwards EA; Summerbell CD; Taylor SJ; Walton RT
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011207. PubMed ID: 31808563
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Ambulatory care pharmacy services: has the agenda changed?
    Carter BL; Helling DK
    Ann Pharmacother; 2000 Jun; 34(6):772-87. PubMed ID: 10860139
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Improving the quality of publications in and advancing the paradigms of clinical and social pharmacy practice research: the Granada Statements.
    Fernandez-Llimos F; Desselle S; Stewart D; Garcia-Cardenas V; Babar ZU; Bond C; Dago A; Jacobsen R; Nørgaard LS; Polidori C; Sanchez-Polo M; Santos-Ramos B; Shcherbakova N; Tonin FS
    Int J Clin Pharm; 2023 Apr; 45(2):285-292. PubMed ID: 36920737
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Advancing ambulatory pharmacy practice through a crisis: Objectives and strategies used in an ambulatory care action team's response to the COVID-19 pandemic.
    Do T; Luon S; Boothe K; Stutsky M; Renauer M
    Am J Health Syst Pharm; 2021 Mar; 78(8):720-725. PubMed ID: 33647947
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Providing patient care through community pharmacies in the UK: policy, practice, and research.
    Noyce PR
    Ann Pharmacother; 2007 May; 41(5):861-8. PubMed ID: 17456540
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Systematic review of medication synchronization in community pharmacy practice.
    Patti M; Renfro CP; Posey R; Wu G; Turner K; Ferreri SP
    Res Social Adm Pharm; 2019 Nov; 15(11):1281-1288. PubMed ID: 30482457
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Using the Consumer Experience with Pharmacy Services Survey as a quality metric for ambulatory care pharmacies: older adults' perspectives.
    Shiyanbola OO; Mott DA; Croes KD
    BMJ Open; 2016 May; 6(5):e011241. PubMed ID: 27231004
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Benefits of developing a collaborative, outcomes-based specialty pharmacy program.
    Pulvermacher A; Nelson C
    Am J Health Syst Pharm; 2016 Jun; 73(11):839-43. PubMed ID: 27126830
    [TBL] [Abstract][Full Text] [Related]  

  • 76. NCCN Task Force Report: Specialty Pharmacy.
    Schwartz RN; Eng KJ; Frieze DA; Gosselin TK; Griffith N; Seung AH; Hinkel JM; Johnson PE; Johnson SA; Li EC; Szabatura AH; Wong MK
    J Natl Compr Canc Netw; 2010 Jul; 8 Suppl 4():S1-12. PubMed ID: 20705807
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Medicare star ratings: stakeholder proceedings on community pharmacy and managed care partnerships in quality.
    Academy of Managed Care Pharmacy ; American Pharmacists Association
    J Am Pharm Assoc (2003); 2014; 54(3):228-40. PubMed ID: 24770440
    [TBL] [Abstract][Full Text] [Related]  

  • 78. ASHP survey of ambulatory care pharmacy practice in health systems--2004.
    Knapp KK; Okamoto MP; Black BL
    Am J Health Syst Pharm; 2005 Feb; 62(3):274-84. PubMed ID: 15719585
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Development and testing of a framework for defining a strategy to address medication adherence during patient encounters in community pharmacies.
    Baumgartner PC; Comment N; Hersberger KE; Arnet I
    Explor Res Clin Soc Pharm; 2022 Mar; 5():100123. PubMed ID: 35478506
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Analyzing the costs of developing and operating an integrated health-system specialty pharmacy: The case of a centralized insurance navigation process for specialty clinic patients.
    Rim MH; Thomas KC; Barrus SA; Ryther AMK; Clawson A; Ferrara F; Jackson CG
    Am J Health Syst Pharm; 2021 May; 78(11):982-988. PubMed ID: 33693452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.